ENT Update

ENT Update

By 洪士涵醫師ScienceHealth & Fitness
Download on the App Store

ENT Update episodes

  • Episode 40 | 2026/05/21
    ENT Update Podcast - 2026/05/21 (週四:睡眠醫學專題)
    討論主題:睡眠呼吸中止症最新治療選擇
    重點整理:
    1. AD109 口服藥 Phase 3 SynAIRgy 成功 — AHI下降55.6%,已送FDA (AJRCCM, May 18 2026)
    2. Zepbound (tirzepatide) 首個FDA核准用於肥胖型OSA藥物
    3. Inspire V 雙側舌下神經刺激器 — 新一代植入裝置
    4. Barbed Suture Pharyngoplasty — 倒刺縫線咽喉整形術
    5. Solriamfetol — 改善OSA白天嗜睡
    製作:洪士涵醫師
    9 min
  • Episode 38 | 2026/05/19
    ENT Update Podcast - 2026/05/19 (週二:耳科與聽力學專題)
    討論文獻:
    1. Otarmeni(lunsotogene parvec) FDA Accelerated Approval - First gene therapy for OTOF hearing loss (Apr 23, 2026)
    2. Envoy Medical Acclaim Fully Implanted CI - 56 patients activated (Apr 2026)
    3. Osia 2 System Audiological Outcomes - Otol Neurotol (Mar 1, 2026)
    4. Polygenic SNHL GWAS - Million Veteran Program, JARO (Mar 16, 2026)
    10 min
  • Episode 37 | 2026/05/18
    本期 ENT Update Podcast(2026/5/18 週一)探討頭頸外科與腫瘤學專題。主持人傅醫師與林醫師辯證式討論以下文獻:
    KEYNOTE-689 圍手術期 Pembrolizumab 用於局部晚期頭頸癌
    - NEJM 2025; DOI: 10.1056/NEJMoa2501065
    - FDA 已核准用於可切除局部晚期 HNSCC 圍手術期治療
    NIVOPOSTOP (GORTEC 2018-01) — 輔助性 Nivolumab 用於高風險頭頸癌
    - Lancet 2026; DOI: 10.1016/S0140-6736(25)02713-7
    - 3年無疾病存活率 63.1% vs 52.5%(HR 0.76)
    TORS 長期腫瘤學預後 — HPV 陽性口咽癌五年存活率接近 90%
    - Otolaryngol Head Neck Surg 2026
    TORS 單一治療吞嚥功能長期追蹤
    - Head & Neck 2026
    SEOM-TTCC 2025 頭頸癌治療指引更新
    - Clin Transl Oncol 2026
    CSCO 2026 頭頸部腫瘤診療指南
    12 min
  • Episode 36-Special | 2026/05/18
    ENT Update 2026-05-18 頭頸部腫瘤特輯
    參考文獻:
    1. Lactylation-driven metabolic-immune crosstalk: CD44, APP causal risk genes in HNSCC. Front Immunol, 15 May 2026. DOI: 10.3389/fimmu.2026.xxxxx
    2. Neural-derived CCL5-Treg-RAMP1 axis: perineural invasion causes immunosuppression. J Immunother Cancer, 8 May 2026. DOI: 10.1136/jitc-2026.xxxxx
    3. EGFR/Cyclin D1/Bcl-2 high expression prognostic meta-analysis. OTO Open, 14 Apr 2026. DOI: 10.1002/oto2.xxxxx
    4. LEAP-010: Pembro+Lenvatinib improves PFS but not OS in R/M HNSCC. JCO, Mar 2026. DOI: 10.1200/JCO.2026.xxxxx
    5. PNI predicts poor Pembrolizumab efficacy. Laryngoscope, Jan 2026. DOI: 10.1002/lary.xxxxx
    6. SLC16A1/MCT1-STAT3-SLC7A11 ferroptosis axis. Oncol Res, 2026. DOI: 10.32604/or.2026.xxxxx
    7. Future of systemic therapy for R/M HNSCC: bispecific Abs & HPV vaccines. Front Oncol, 26 Mar 2026. DOI: 10.3389/fonc.2026.xxxxx
    8. Personalized medicine: ctDNA de-escalation, risk-adapted CRT. Front Oncol, 15 May 2026. DOI: 10.3389/fonc.2026.xxxxx
    9. Anterior skull base ACC: GTR + proton therapy optimal. Eur J Cancer, May 2026. DOI: 10.1016/j.ejca.2026.xxxxx
    10. PROMs quality of life clinical application. Qual Life Res, May 2026. DOI: 10.1007/s11136-026-xxxxx
    12 min
  • Episode 35 | 2026/05/17
    ENT Update Podcast - 2026年5月17日 (一週專題回顧)
    參考文獻:
    1. SEOM-TTCC HNC guidelines. Clin Transl Oncol. 2026 Mar 17.
    2. NIVOPOST-OP. Lancet. 2026 Jan 24.
    3. Neoadjuvant chemoimmunotherapy HNC. PMID: 41842604
    4. CI in Asymmetric Hearing Loss. Otol Neurotol. 2026 Mar.
    5. Biologics CRSwNP. PMID: 41518424
    6. THN3 pHGNS 3yr. Chest 2026 May. DOI: 10.1016/j.chest.2025.11.057
    7. OSPREY pHGNS. Annals Intern Med. 2026 Apr 20.
    8. Hydrogel vocal cord. Biomaterials. McGill. 2026.
    9. OBIL UVFP. PMID: 41353483
    10. AI CADx Laryngoscopy. OTO HNS. 2026 Feb. DOI: 10.1002/ohn.70153
    11. DL scoping OHNS. Nature Digital Med. 2025.
    12. DL model ENT. Sci Rep. 2026 Feb 10.
    6 min
  • Episode 34-Special | 2026/05/16
    睡眠外科特輯|PPPP|OSA+LPR|舌骨懸吊|pHGNS 3年|HNS分期|OSPREY|機器人舌根|術前篩檢|唐氏症兒童|ENT Update Podcast
    13 min
  • Episode 33 | 2026/05/16
    ENT Update Podcast - 2026/05/16
    主題:人工智慧在耳鼻喉科應用
    本集討論文獻:
    1. Integration of AI into ENT practice: comparative study
    Egypt J Otolaryngol (2026 Mar 23)
    DOI: 10.1186/s43163-026-01055-x
    URL: https://link.springer.com/article/10.1186/s43163-026-01055-x
    2. Generative AI in otolaryngology (Kowalski et al.)
    Otorhinolaryngol 2026;76(1):23-35
    DOI: 10.23736/S2724-6302.26.02601-0
    3. ML prediction of eosinophilic CRSwNP
    PMID: 41847830 (2026 Mar 18)
    URL: https://pubmed.ncbi.nlm.nih.gov/41847830/
    15 min
  • Episode 32 | 2026/05/15
    ENT Update Podcast - 2026/05/15 - 喉科學與聲音醫學
    References:
    1. AAO-HNS/ASHA Consensus Statement on the Use of Voice Therapy in the Treatment of Dysphonia (2026 Mar 3). https://www.entnet.org/resource/consensus-statement-on-the-use-of-voice-therapy-in-the-treatment-of-dysphonia/
    2. Treatment Efficacy for Functional Voice Disorders with Dysphonia: A Network Meta-analysis. Journal of Voice (2026 Mar 3). https://www.sciencedirect.com/science/article/pii/S0892199726000676
    3. Intralesional Steroid Injection vs Voice Therapy for Early Vocal Fold Nodules: An RCT. European Archives of Oto-Rhino-Laryngology (2025 Dec 29). https://link.springer.com/article/10.1007/s00405-025-09923-7
    4. Outcomes of Voice Therapy in Organic Voice Disorders: A Scoping Review. Journal of Voice (2026 May 5). https://www.sciencedirect.com/science/article/pii/S0892199726001335
    5. Long-Term Retention of Voice Therapy Outcomes After Discharge. Journal of Voice (2025 Dec 18). PubMed: 41419425
    6. Clinical Applications of Laryngeal Ultrasonography: A Review. Journal of Voice (2025 Oct 29). PubMed: 41168021
    7. Family-Involved Hybrid Voice Therapy for Pediatric VF Nodules. Laryngoscope Investigative Otolaryngology (2026 Apr 30). https://onlinelibrary.wiley.com/doi/full/10.1002/lio2.70422
    8. Barriers and Readiness to Voice Therapy Among School Teachers. Journal of Voice (2025 Jul 29).
    18 min
  • Episode 31 | 2026/05/14
    ENT Update Podcast - 2026年5月14日 (週四)
    主題:睡眠醫學
    本集參考文獻:
    1. Tirzepatide on OSA-related cardiometabolic risk: SURMOUNT-OSA secondary analysis
    Nature Medicine, January 2026
    DOI: 10.1038/s41591-025-04071-1
    https://www.nature.com/articles/s41591-025-04071-1
    2. Proximal hypoglossal nerve stimulation for OSA: A randomized controlled trial
    The Lancet Respiratory Medicine, April 2026
    https://medicalxpress.com/news/2026-04-implanted-nerve-obstructive-apnea-safe.html
    3. SleepFM: AI model predicts disease risk from sleep data
    Nature Medicine / Stanford Medicine, January 2026
    https://med.stanford.edu/news/all-news/2026/01/ai-sleep-disease.html
    4. Mayo Clinic AI-enabled ECG analysis for OSA detection
    AASM Key Trends in Sleep Medicine Q1 2026
    https://aasm.org/key-trends-in-sleep-medicine-q1-2026/
    5. Growth and sleep outcomes after adenotonsillectomy in pediatric OSA
    Scientific Reports, December 2025
    DOI: 10.1038/s41598-025-30271-3
    https://www.nature.com/articles/s41598-025-30271-3
    6. Long-term Health Outcomes of Pediatric OSA
    Sleep Medicine, May 2026
    https://www.sciencedirect.com/science/article/abs/pii/S1389945726002480
    7. Pediatric DISE-directed surgery outcomes in OSA
    Otolaryngology-Head and Neck Surgery, February 2026
    DOI: 10.1002/ohn.70166
    https://aao-hnsfjournals.onlinelibrary.wiley.com/doi/10.1002/ohn.70166
    主持人:傅醫師 (zh-TW-YunJheNeural) 與 林醫師 (zh-TW-HsiaoChenNeural)
    語速:+12%
    12 min

About ENT Update

From the publisher's feed

Ear, nose and throat head and neck medicine latest information. Weekly curated international literature, research progress and clinical updates for medical professionals. Content includes: otology,…